Professor
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
Dr. Hadjipanayis is a board-certified neurosurgeon who has devoted his entire career to the treatment of brain tumor patients. He completed his neurosurgical residency and graduate Ph.D. training at the University of Pittsburgh School of Medicine with additional neurosurgical oncology training at the University of California San Francisco. He is the inaugural L. Dade Lunsford Professor of Neurological Surgery at UPMC and will serve as Executive Vice-Chairman for the Dept. of Neurological Surgery. Dr. Hadjipanayis has taken over as Director of the UPMC Center for Image-Guided Neurosurgery from his mentor Dr. L. Dade Lunsford. He will also serve as Co-Director of the newly formed UPMC Brain Tumor Center at the Hillman Cancer Center. Dr. Hadjipanayis directs the Brain Tumor Nanotechnology Laboratory in the Hillman Cancer Center and has been the principal investigator of multiple clinical trials and university-, private foundation-, and NIH-funded grants focused on brain tumors. He was recently recruited back from the Icahn School of Medicine at Mount Sinai in New York City where he served as the Chairman of Neurosurgery at Mount Sinai Union Square/Beth Israel and the Director of Neurosurgical Oncology for the Mount Sinai Health System. Dr. Hadjipanayis has focused much of his career on innovation, translational research, and intraoperative technology development. In 2011, Dr. Hadjipanayis was the first to use 5-ALA (Gleolan) and perform fluorescence-guided surgery (FGS) in the US and helped lead the FDA approval of Gleolan for glioma surgery in June 2017. He has also led the development of a voice-controlled robotic-assisted exoscope for neurosurgery. He is an elected member of the American Academy of Neurological Surgeons and the Society of Neurological Surgeons (SNS). Dr. Hadjipanayis has been a tireless brain tumor advocate serving on the nonprofit boards of the Southeastern Brain Tumor Foundation (SBTF) and StacheStrong.
(PC2203) Practical Clinic: Technological Adjuncts for Malignant Brain Tumor Surgery
Friday, April 21, 2023
8:00am – 11:30am PST
Disclosure(s): Hemerion: Consultant (Ongoing); Stryker Co.: Consultant (Ongoing); Synaptive Medical: Consultant (Ongoing)
Saturday, April 22, 2023
3:00pm – 3:30pm PST
Disclosure(s): Hemerion: Consultant (Ongoing); Stryker Co.: Consultant (Ongoing); Synaptive Medical: Consultant (Ongoing)
(NC5505) GBM Fluorescence-guided Surgery and Photodynamic Therapy
Monday, April 24, 2023
10:24am – 10:38am PST
Disclosure(s): Hemerion: Consultant (Ongoing); Stryker Co.: Consultant (Ongoing); Synaptive Medical: Consultant (Ongoing)